Literature DB >> 2713268

Cataracts associated with long-term topical steroids.

C Costagliola, B Cati-Giovannelli, A Piccirillo, M Delfino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2713268     DOI： 10.1111/j.1365-2133.1989.tb04181.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety.

Authors:  Veysi Oner; Fatih Mehmet Türkcü; Mehmet Taş; Mehmet Fuat Alakuş; Yalçın Işcan
Journal:  Jpn J Ophthalmol       Date:  2012-05-25       Impact factor: 2.447

2.  Loss of αB-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart.

Authors:  Sanjay Mishra; Shu-Yu Wu; Alexandra W Fuller; Zhen Wang; Kristie L Rose; Kevin L Schey; Hassane S Mchaourab
Journal:  J Biol Chem       Date:  2017-11-21       Impact factor: 5.157

3.  Periocular steroid ointments may cause ocular damage.

Authors:  C J McLean; R F Lobo; D J Brazier
Journal:  BMJ       Date:  1994 Aug 20-27

4.  Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery.

Authors:  Timothy L Comstock; Michael R Paterno; Angele Singh; Tara Erb; Elizabeth Davis
Journal:  Clin Ophthalmol       Date:  2011-02-10

Review 5.  The Role of Alpha-MSH as a Modulator of Ocular Immunobiology Exemplifies Mechanistic Differences between Melanocortins and Steroids.

Authors:  Christine M Clemson; John Yost; Andrew W Taylor
Journal:  Ocul Immunol Inflamm       Date:  2016-01-25       Impact factor: 3.070
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.